Blog
Is ExxonMobil Positioned to Capitalize on Rising LNG & Power Demand?
Exxon Mobil Corporation XOM maintains a diversified global portfolio with a strategic presence in upstream and downstream operations. The majority of revenues are generated from its advantaged
Can Comfort Systems' $12.45B Backlog Sustain Its Growth Momentum?
Comfort Systems USA, Inc. FIX entered 2026 with extraordinary momentum, but investors are now asking whether its record-breaking backlog can continue fueling its rapid expansion. After posting
Can Sterling's Cross-Selling Strategy Unlock Bigger AI Contracts?
Sterling Infrastructure, Inc. STRL is rapidly transforming from a traditional site-development contractor into a full-scale mission-critical infrastructure partner, and its cross-selling strategy
Keysight Q2 Earnings Surpass Estimates on Solid Revenue Growth
Keysight Technologies, Inc. KEYS reported mixed second-quarter fiscal 2026 results, with the bottom line beating the Zacks Consensus Estimate while the top line missing the same. The leading
PLTR's Customer Growth Momentum Strengthens Enterprise AI Expansion
Palantir Technologies PLTR continues to demonstrate strong momentum in customer acquisition, highlighting growing enterprise demand for its artificial intelligence and data analytics platforms
Brand Strength, Innovations & Digital Growth Aid PVH's Performance
PVH Corporation PVH benefits from strength in its core brands, such as Calvin Klein and Tommy Hilfiger, which continue to leverage solid global recognition and strong pricing power across markets
How Is KTOS Strengthening Revenue Visibility Through Its Backlog?
Kratos Defense & Security Solutions, Inc. KTOS continues strengthening its revenue visibility through a growing backlog tied to defense, satellite communications and unmanned systems programs. As of
Best Momentum Stocks to Buy for May 20th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 20:
Lumentum Holdings Inc. LITE: This photonics company has a Zacks Rank #1 and witnessed
Here's Why You Should Retain Equifax Stock in Your Portfolio for Now
Equifax’s EFX sustained revenue growth momentum is driven by its diverse offerings. New acquisitions and AI innovations in analytical tools and solutions boost customer gains.
EFX has a Growth Score
Earnings Preview: Dick's Sporting Goods (DKS) Q1 Earnings Expected to Decline
The market expects Dick's Sporting Goods (DKS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known
Bath & Body Works (BBWI) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Bath & Body Works (BBWI) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2026. This widely-known consensus
Salesforce (CRM) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Salesforce (CRM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook
Analysts Estimate Abercrombie & Fitch (ANF) to Report a Decline in Earnings: What to Look Out for
The market expects Abercrombie & Fitch (ANF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus
Should Buy Japan ETFs as Economy Beats Estimates in Q1?
Japan’s economy expanded at an annualized rate of 2.1% in the first quarter of 2026, topping analysts’ expectations on the back of stronger consumption and robust exports. The growth rate was higher
Here's Why Investors Should Give United Airlines Stock a Miss Now
United Airlines UAL is facing significant challenges from increased expenses and weak liquidity. These factors are adversely affecting the company’s bottom line, making it an unattractive choice for
Abercrombie Pre-Q1 Earnings: Will Hollister Strength Aid Performance?
Abercrombie & Fitch Co. ANF is scheduled to report first-quarter fiscal 2026 results on May 27, before the opening bell.The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at
PNC's Expansion Strategy: Growth Through Acquisitions & Partnerships
The PNC Financial Services Group, Inc. PNC is pursuing growth with a clear strategy to expand in attractive markets, deepen customer relationships and strengthen fee-based capabilities through
Does Healthcare Services (HCSG) Have the Potential to Rally 26.02% as Wall Street Analysts Expect?
Shares of Healthcare Services (HCSG) have gained 7.4% over the past four weeks to close the last trading session at $20.79, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 27.84% Upside in First American Financial (FAF): Can the Stock Really Move This High?
First American Financial (FAF) closed the last trading session at $67.43, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Does Ranpak Holdings (PACK) Have the Potential to Rally 27.11% as Wall Street Analysts Expect?
Ranpak Holdings Corp (PACK) closed the last trading session at $5.57, gaining 33.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Here's Why Novanta (NOVT) Looks Ripe for Bottom Fishing
The price trend for Novanta (NOVT) has been bearish lately and the stock has lost 7.3% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that
Here's Why Strive, Inc. (ASST) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in Strive, Inc. (ASST) lately. While the stock has lost 5.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87%
Omnicell (OMCL) closed the last trading session at $43.82, gaining 19.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now
The price trend for X4 Pharmaceuticals (XFOR) has been bearish lately and the stock has lost 16.1% over the past week. However, the formation of a hammer chart pattern in its last trading session



